Supratherapeutic anticoagulation observed during the pandemicThe MHRA has been contacted by King’s College Hospital in London regarding their concerns over an apparent increase in the number of patients taking warfarin…
The MHRA has received several enquiries about whether organisations can ‘pack down’ large packs of licenced medicinal products into smaller quantities for retail sale.Any packs prepared under this guidance cannot…
All virtual manufacturers must now hold the full technical documentation for any product they place on the market under their name.
This guidance applies until such time as the Windsor Framework takes effect on 1 January 2025. Under the Windsor Framework, rather than novel medicines for use in Northern Ireland requiring…
Information on naming, presentation and packaging when submitting a notification of intent to market e-cigarette and vape products in Great Britain.
